Concentric Medical's modified neurovascular retriever:
This article was originally published in Clinica
Executive Summary
The Merci L6 Retriever, a device intended to restore blood flow in the neurovasculature by removing thrombi in patients experiencing ischaemic stroke, has received 510(k) clearance in the US. The product, developed by Concentric Medical, of Mountain View, California, is indicated for use in patients who are ineligible for, or unresponsive to, treatment with intravenous tissue plasminogen activator - clot-dissolving therapy. It may also be used in the retrieval of foreign bodies misplaced during interventional radiological procedures in the neurovasculature or the peripheral or coronary vasculature. The Merci L6 Retriever is a shaped Nitinol wire which can be delivered using standard catheterisation techniques, whereby a small puncture in the groin is used to introduce the retriever into an artery leading to the brain. Upon reaching the targeted area, the Merci retriever is deployed and returns to its original shape. The device incorporates a 2.7mm cylindrical helix with attached filaments; these provide an additional mechanism for securing the clot during retrieval.
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.